Apyx Medical Corp reports results for the quarter ended June 30 - Earnings Summary

• Apyx Medical Corp APYX.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -19 cents. The mean expectation of three analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -10 cents to -8 cents per share.

• Revenue fell 6.4% to $11.37 million from a year ago; analysts expected $11.70 million.

• Apyx Medical Corp's reported EPS for the quarter was a loss of 9 cents​.

• The company reported a quarterly loss of $3.78 million.

• Apyx Medical Corp shares had fallen by 9.3% this quarter and gained 29.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Apyx Medical Corp is $4.00, about 51% above its last closing price of $1.96

This summary was machine generated from LSEG data August 8 at 03:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)